Plato Investment Management Ltd Buys 400 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Plato Investment Management Ltd boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 22.2% in the third quarter, Holdings Channel reports. The firm owned 2,199 shares of the biotechnology company’s stock after acquiring an additional 400 shares during the period. Plato Investment Management Ltd’s holdings in Axon Enterprise were worth $878,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. PFG Investments LLC boosted its position in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after purchasing an additional 25 shares during the period. Gladstone Institutional Advisory LLC boosted its position in shares of Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after acquiring an additional 26 shares during the period. Mather Group LLC. boosted its position in shares of Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after acquiring an additional 27 shares during the period. CWM LLC boosted its position in shares of Axon Enterprise by 1.3% in the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after acquiring an additional 36 shares during the period. Finally, SPC Financial Inc. boosted its position in shares of Axon Enterprise by 2.2% in the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after acquiring an additional 38 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In other news, President Joshua Isner sold 25,811 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the sale, the president now directly owns 228,166 shares in the company, valued at approximately $82,103,253.44. This trade represents a 10.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the sale, the director now owns 7,379 shares of the company’s stock, valued at approximately $2,752,588.37. This trade represents a 5.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 411,006 shares of company stock worth $161,360,618 over the last three months. 6.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on AXON. Robert W. Baird increased their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Barclays increased their price objective on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Craig Hallum upped their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $604.56 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a fifty day moving average price of $433.89 and a two-hundred day moving average price of $355.28. Axon Enterprise, Inc. has a 52-week low of $220.77 and a 52-week high of $624.84. The firm has a market capitalization of $46.10 billion, a P/E ratio of 156.22, a P/E/G ratio of 15.10 and a beta of 0.94.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.